CN | EN

Countdown to 2018 CBIIC:

ZHOU Hao

Partner and General Manager of Biotree Capital


20 years of experience in medical industry, involving pharmaceutical R&D, innovative medical enterprise incubation and management, domestic and international primary and secondary market research and investment experience;Served as co-founding partner of 3E Capital and completed the investment and incubation of a number of domestic and international projects including innovative drugs, medical devices and medical service;Served as head of China Renaissance investment bank business, focusing on the health care sector; Extensive experience in domestic and international secondary market of medical industry: Served as medical industry analyst for UBS on Wall Street for 6 years and got the best analyst of life science industry of the United States, Served as senior medical industry analyst for China International Fund Management and Hong Kong Piper Jaffray Asia for more than 3 years;5 years of biotechnology R&D experience in DuPont, USA; Education: Bachelor of Clinical Medicine, Shanghai Medical College (now Fudan Medical College); Master of Biochemistry and MBA, America